Peloton Therapeutics Inc (PLTX)

NASDAQ
Currency in USD
0.00
0.00(0.00%)
Closed·
Showing Peloton Therapeutics historical data. For real-time data please try another search
Day's Range
0.000.00
52 wk Range
0.000.00
Key Statistics
Edit
Prev. Close
-
Open
-
Day's Range
-
52 wk Range
0-0
Volume
-
Average Volume (3m)
0
1-Year Change
-
Book Value / Share
-
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock

Peloton Therapeutics Company Profile

Peloton Therapeutics, Inc. operates as a clinical stage biopharmaceutical company. The company develops medicines for patients with cancer and other debilitating or life-threatening conditions. Its lead drug candidate includes PT2977, an oral HIF-2a inhibitor for patients with advanced or metastatic clear cell renal cell carcinoma (mRCC); PT2977 for von Hippel-Lindau disease associated renal cell carcinoma; and PT2567, an oral HIF-2a inhibitor in preclinical development for non-oncology indications, including pulmonary arterial hypertension. The company was formerly known as Damascus Pharmaceutics, Inc. and changed its name to Peloton Therapeutics, Inc. in June 2011. Peloton Therapeutics, Inc. was incorporated in 2010 and is headquartered in Dallas, Texas. As of July 30, 2019, Peloton Therapeutics, Inc. operates as a subsidiary of Merck & Co., Inc.

Employees
64

Earnings

Latest Release
Apr 26, 2019
EPS / Forecast
-1.08 / --
Revenue / Forecast
-- / --
EPS Revisions
Last 90 days

PLTX Income Statement

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.